Abstract Recent FDA approval of new GLP-1 agonists drugs focused on weight loss has been met with a surge in use of drugs such as Wegovy and Zebound
99% Purity : Manufactured with 99% purity , GLP-1 R (50mg) ensures the highest quality for preclinical studies , clinical trials , and metabolic health research , offering consistent and reliable results
Oral Wegovy and Foundayo for Convenience and Flexibility For those who prefer a non-injection option, Oral Wegovy is the first oral GLP-1 medication approved for weight management, achieving 16.6% mean body weight loss in trials
Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al
Study 7 was a 64-week trial that enrolled 307 patients with obesity (BMI greater than or equal to 30 kg/m2) or with overweight (BMI 27-29.9 kg/m2) and at least one weight-related comorbid condition, such as treated or untreated dyslipidemia or hypertension
These drug manufacturers didnt share these findings with doctors so that they could adjust their patients dosage, which would have potentially reduced their risk for this condition